Artal Group S.A. Rigel Pharmaceuticals Inc Transaction History

Artal Group S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.22 - $3.45 $712,842 - $1.11 Million	-321,100 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$1.78 - $4.13 $30,082 - $69,797	-16,900 Reduced 5.0%	321,100 $771,000
Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.05 $16,920 - $24,599	-12,000 Reduced 3.43%	338,000 $619,000
Q1 2020 May 14, 2020	BUY	$1.27 - $3.0 $444,500 - $1.05 Million	350,000 New	350,000 $546,000

365K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $7.26B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.